ENTITY
Viva Biotech Holdings

Viva Biotech Holdings (1873 HK)

73
Analysis
Health CareChina
Viva Biotech Holdings operates as a drug discovery platform. The Company provides target protein expression, structure researching, hit screening, drug candidate determination, and other services. Viva Biotech Holdings serves customers worldwide.
more
06 Aug 2020 14:57

Tigermed IPO: Trading Debut

Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
416 Views
Share
27 Jul 2020 14:38

Tigermed IPO: Valuation Insights

Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
419 Views
Share
20 Jul 2020 01:00

Tigermed IPO: PHIP Highlights the Trade-Offs

Hangzhou Tigermed Consulting (300347 CH) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
374 Views
Share
26 Apr 2020 20:49

Tigermed IPO Initiation: Trade-Offs

Hangzhou Tigermed Consulting (300347 CH) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
417 Views
Share
bullishChina Feihe
09 Mar 2020 12:05

Trade Idea Update/HK Connect Weekly: Inclusion Effective Today, XD +10%

In this insight, we will provide an update on the inclusion news today and recap on the basket performance of stocks that are included into the...

Logo
303 Views
Share
x